494120.Kq
The company operates in the Advanced Medical Equipment & Technology industry, providing specialized healthcare services and equipment, primarily generating revenue through the development and sale of advanced medical technologies.
Business. The company operates in the Advanced Medical Equipment & Technology industry, providing specialized healthcare services and equipment, primarily generating revenue through the development and sale of advanced medical technologies.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Advanced Medical Equipment & Technology industry, providing specialized healthcare services and equipment, primarily generating revenue through the development and sale of advanced medical technologies.
The company maintains a strong liquidity position, with a current ratio of 8.8, indicating a significant buffer of current assets over current liabilities. Its cash and equivalents amount to 23,670,706,920 KRW, which is a substantial portion of its total assets of 34,228,606,160 KRW. The debt-to-equity ratio is 0.11, suggesting a conservative capital structure with minimal reliance on debt financing.
Profitability metrics are negative, with a return on equity of -27.89% and a return on assets of -22.98%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets to generate profit. The operating income is -7,525,764,110 KRW, and the net income is -7,864,272,240 KRW, reflecting a significant financial loss.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to higher operational and market risks if the segment or region experiences a downturn.
The company's growth trajectory is currently negative, with a significant decline in operating and net income. Analyst estimates suggest a mean revenue estimate of 163,000,000 KRW, which is a substantial drop from the last actual revenue of 7,303,000,000 KRW. The mean EBIT estimate is -5,500,000 KRW, indicating continued operational losses.
Risk factors include the company's negative cash flow from operations, with an operating cash flow of -7,348,638,190 KRW and a free cash flow of -9,206,868,440 KRW. These figures suggest the company is not generating sufficient cash to sustain operations or fund growth. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected.
Recent events include the disclosure of significant financial losses in the latest financial statements. The company's operating and net income are both negative, and the cash flow from operations is also negative. These developments may impact investor confidence and the company's ability to secure additional financing.
- The company has a strong liquidity position with a high current ratio and significant cash reserves.
- Profitability is negative, with both return on equity and return on assets below zero.
- The company's revenue is concentrated in a single segment, increasing operational risk.
- Growth is currently negative, with a significant decline in revenue and operating income.
- The company faces liquidity and cash flow challenges, with negative operating and free cash flows.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -92,10 |
| Revenue | —no estimate | —no estimate | 163,0M KRW |
| Operating income | —no estimate | —no estimate | -5,5M KRW |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 494120.KQ Market data — financials · 2026-05-26
- Curiosis Inc Market data — analyst estimates · 2026-05-26